nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—CYP1A2—chronic obstructive pulmonary disease	0.487	1	CbGaD
Cinacalcet—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0533	0.15	CbGbCtD
Cinacalcet—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0516	0.145	CbGbCtD
Cinacalcet—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0516	0.145	CbGbCtD
Cinacalcet—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.046	0.129	CbGbCtD
Cinacalcet—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0433	0.122	CbGbCtD
Cinacalcet—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0293	0.0821	CbGbCtD
Cinacalcet—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0279	0.0783	CbGbCtD
Cinacalcet—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0249	0.0698	CbGbCtD
Cinacalcet—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0146	0.041	CbGbCtD
Cinacalcet—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0138	0.0387	CbGbCtD
Cinacalcet—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00191	0.0563	CbGpPWpGaD
Cinacalcet—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00166	0.0492	CbGpPWpGaD
Cinacalcet—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00147	0.0435	CbGpPWpGaD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—EGFR—chronic obstructive pulmonary disease	0.00132	0.039	CbGpPWpGaD
Cinacalcet—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.0012	0.0356	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000862	0.0255	CbGpPWpGaD
Cinacalcet—Dexfenfluramine—SLC6A4—chronic obstructive pulmonary disease	0.000757	0.16	CrCbGaD
Cinacalcet—Dexfenfluramine—CYP1A2—chronic obstructive pulmonary disease	0.000689	0.145	CrCbGaD
Cinacalcet—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.000643	0.00543	CcSEcCtD
Cinacalcet—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000632	0.00534	CcSEcCtD
Cinacalcet—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000628	0.00531	CcSEcCtD
Cinacalcet—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000626	0.00528	CcSEcCtD
Cinacalcet—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000625	0.00528	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00062	0.00523	CcSEcCtD
Cinacalcet—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000611	0.0181	CbGpPWpGaD
Cinacalcet—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00061	0.00515	CcSEcCtD
Cinacalcet—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000607	0.0179	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000583	0.00492	CcSEcCtD
Cinacalcet—CASR—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.00058	0.0172	CbGpPWpGaD
Cinacalcet—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000568	0.00479	CcSEcCtD
Cinacalcet—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00056	0.00473	CcSEcCtD
Cinacalcet—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000557	0.0047	CcSEcCtD
Cinacalcet—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000557	0.0047	CcSEcCtD
Cinacalcet—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000557	0.0047	CcSEcCtD
Cinacalcet—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000541	0.00457	CcSEcCtD
Cinacalcet—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000532	0.00449	CcSEcCtD
Cinacalcet—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000526	0.00445	CcSEcCtD
Cinacalcet—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000524	0.00443	CcSEcCtD
Cinacalcet—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000523	0.00442	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000522	0.0154	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000519	0.0153	CbGpPWpGaD
Cinacalcet—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000519	0.00438	CcSEcCtD
Cinacalcet—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000519	0.00438	CcSEcCtD
Cinacalcet—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000519	0.00438	CcSEcCtD
Cinacalcet—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000517	0.00437	CcSEcCtD
Cinacalcet—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000517	0.0153	CbGpPWpGaD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000515	0.00435	CcSEcCtD
Cinacalcet—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00051	0.00431	CcSEcCtD
Cinacalcet—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00051	0.00431	CcSEcCtD
Cinacalcet—CASR—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000508	0.015	CbGpPWpGaD
Cinacalcet—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000505	0.00426	CcSEcCtD
Cinacalcet—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000505	0.00426	CcSEcCtD
Cinacalcet—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000503	0.00425	CcSEcCtD
Cinacalcet—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000503	0.00425	CcSEcCtD
Cinacalcet—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.0005	0.00422	CcSEcCtD
Cinacalcet—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000499	0.00421	CcSEcCtD
Cinacalcet—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000498	0.00421	CcSEcCtD
Cinacalcet—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000496	0.00419	CcSEcCtD
Cinacalcet—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000494	0.00417	CcSEcCtD
Cinacalcet—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000493	0.00416	CcSEcCtD
Cinacalcet—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000492	0.00416	CcSEcCtD
Cinacalcet—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000492	0.00416	CcSEcCtD
Cinacalcet—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000488	0.00412	CcSEcCtD
Cinacalcet—Duloxetine—SLC6A4—chronic obstructive pulmonary disease	0.000488	0.103	CrCbGaD
Cinacalcet—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000483	0.00408	CcSEcCtD
Cinacalcet—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000482	0.0143	CbGpPWpGaD
Cinacalcet—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000482	0.00407	CcSEcCtD
Cinacalcet—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000477	0.00403	CcSEcCtD
Cinacalcet—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000473	0.00399	CcSEcCtD
Cinacalcet—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000473	0.00399	CcSEcCtD
Cinacalcet—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00047	0.0139	CbGpPWpGaD
Cinacalcet—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00047	0.00397	CcSEcCtD
Cinacalcet—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000468	0.0138	CbGpPWpGaD
Cinacalcet—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000465	0.00392	CcSEcCtD
Cinacalcet—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000464	0.00392	CcSEcCtD
Cinacalcet—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000463	0.00391	CcSEcCtD
Cinacalcet—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000459	0.00387	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000454	0.0134	CbGpPWpGaD
Cinacalcet—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000453	0.00383	CcSEcCtD
Cinacalcet—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00045	0.0038	CcSEcCtD
Cinacalcet—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00045	0.0038	CcSEcCtD
Cinacalcet—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000447	0.00377	CcSEcCtD
Cinacalcet—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000447	0.00377	CcSEcCtD
Cinacalcet—Duloxetine—CYP1A2—chronic obstructive pulmonary disease	0.000444	0.0936	CrCbGaD
Cinacalcet—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00044	0.00372	CcSEcCtD
Cinacalcet—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000438	0.0037	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000431	0.00364	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00043	0.00363	CcSEcCtD
Cinacalcet—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000429	0.00363	CcSEcCtD
Cinacalcet—Cough—Formoterol—chronic obstructive pulmonary disease	0.000429	0.00363	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000428	0.0126	CbGpPWpGaD
Cinacalcet—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000425	0.00359	CcSEcCtD
Cinacalcet—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000425	0.00359	CcSEcCtD
Cinacalcet—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000425	0.00359	CcSEcCtD
Cinacalcet—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000424	0.00358	CcSEcCtD
Cinacalcet—Cough—Montelukast—chronic obstructive pulmonary disease	0.00042	0.00355	CcSEcCtD
Cinacalcet—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000419	0.00354	CcSEcCtD
Cinacalcet—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00354	CcSEcCtD
Cinacalcet—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00354	CcSEcCtD
Cinacalcet—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00354	CcSEcCtD
Cinacalcet—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00354	CcSEcCtD
Cinacalcet—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00354	CcSEcCtD
Cinacalcet—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00354	CcSEcCtD
Cinacalcet—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000417	0.00353	CcSEcCtD
Cinacalcet—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000417	0.00352	CcSEcCtD
Cinacalcet—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000417	0.00352	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00351	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00351	CcSEcCtD
Cinacalcet—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00041	0.00346	CcSEcCtD
Cinacalcet—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00041	0.00346	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000407	0.00344	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000407	0.00344	CcSEcCtD
Cinacalcet—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000405	0.00342	CcSEcCtD
Cinacalcet—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000403	0.0119	CbGpPWpGaD
Cinacalcet—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000401	0.00339	CcSEcCtD
Cinacalcet—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000399	0.00337	CcSEcCtD
Cinacalcet—Infection—Formoterol—chronic obstructive pulmonary disease	0.000399	0.00337	CcSEcCtD
Cinacalcet—Fluoxetine—SLC6A4—chronic obstructive pulmonary disease	0.000398	0.0838	CrCbGaD
Cinacalcet—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.00334	CcSEcCtD
Cinacalcet—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.00334	CcSEcCtD
Cinacalcet—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.00334	CcSEcCtD
Cinacalcet—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000395	0.00334	CcSEcCtD
Cinacalcet—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000394	0.00333	CcSEcCtD
Cinacalcet—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000394	0.00333	CcSEcCtD
Cinacalcet—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000393	0.00332	CcSEcCtD
Cinacalcet—Infection—Montelukast—chronic obstructive pulmonary disease	0.000391	0.0033	CcSEcCtD
Cinacalcet—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00039	0.00329	CcSEcCtD
Cinacalcet—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00039	0.00329	CcSEcCtD
Cinacalcet—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000389	0.00328	CcSEcCtD
Cinacalcet—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000388	0.0115	CbGpPWpGaD
Cinacalcet—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000386	0.00326	CcSEcCtD
Cinacalcet—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000382	0.00323	CcSEcCtD
Cinacalcet—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000377	0.00318	CcSEcCtD
Cinacalcet—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.00317	CcSEcCtD
Cinacalcet—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000375	0.00317	CcSEcCtD
Cinacalcet—Duloxetine—HTR2A—chronic obstructive pulmonary disease	0.000375	0.079	CrCbGaD
Cinacalcet—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000373	0.00315	CcSEcCtD
Cinacalcet—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000372	0.00314	CcSEcCtD
Cinacalcet—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.00311	CcSEcCtD
Cinacalcet—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000367	0.0031	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000366	0.0108	CbGpPWpGaD
Cinacalcet—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000366	0.00309	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.00309	CcSEcCtD
Cinacalcet—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000363	0.0107	CbGpPWpGaD
Cinacalcet—Fluoxetine—CYP1A2—chronic obstructive pulmonary disease	0.000362	0.0763	CrCbGaD
Cinacalcet—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00305	CcSEcCtD
Cinacalcet—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000361	0.00305	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000358	0.00303	CcSEcCtD
Cinacalcet—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000358	0.00302	CcSEcCtD
Cinacalcet—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.00302	CcSEcCtD
Cinacalcet—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00299	CcSEcCtD
Cinacalcet—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000353	0.00299	CcSEcCtD
Cinacalcet—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000353	0.00299	CcSEcCtD
Cinacalcet—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000353	0.00298	CcSEcCtD
Cinacalcet—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000352	0.00297	CcSEcCtD
Cinacalcet—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.00035	0.0104	CbGpPWpGaD
Cinacalcet—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.00035	0.0104	CbGpPWpGaD
Cinacalcet—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000349	0.00295	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000347	0.00293	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000347	0.00293	CcSEcCtD
Cinacalcet—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000346	0.00292	CcSEcCtD
Cinacalcet—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000346	0.00292	CcSEcCtD
Cinacalcet—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000346	0.00292	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00292	CcSEcCtD
Cinacalcet—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000343	0.0029	CcSEcCtD
Cinacalcet—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.0029	CcSEcCtD
Cinacalcet—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.00288	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00034	0.00287	CcSEcCtD
Cinacalcet—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000339	0.00286	CcSEcCtD
Cinacalcet—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00285	CcSEcCtD
Cinacalcet—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000335	0.00283	CcSEcCtD
Cinacalcet—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.00282	CcSEcCtD
Cinacalcet—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000333	0.00281	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000332	0.00982	CbGpPWpGaD
Cinacalcet—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000332	0.00281	CcSEcCtD
Cinacalcet—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00033	0.00279	CcSEcCtD
Cinacalcet—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00278	CcSEcCtD
Cinacalcet—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000329	0.00278	CcSEcCtD
Cinacalcet—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000329	0.00278	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000328	0.00277	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.00277	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000328	0.00968	CbGpPWpGaD
Cinacalcet—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00276	CcSEcCtD
Cinacalcet—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00276	CcSEcCtD
Cinacalcet—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00274	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000322	0.00272	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000321	0.00272	CcSEcCtD
Cinacalcet—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000319	0.00269	CcSEcCtD
Cinacalcet—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000319	0.00269	CcSEcCtD
Cinacalcet—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.00268	CcSEcCtD
Cinacalcet—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000317	0.00268	CcSEcCtD
Cinacalcet—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000317	0.00268	CcSEcCtD
Cinacalcet—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.00268	CcSEcCtD
Cinacalcet—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000316	0.00267	CcSEcCtD
Cinacalcet—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000315	0.00932	CbGpPWpGaD
Cinacalcet—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000314	0.00265	CcSEcCtD
Cinacalcet—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000313	0.00265	CcSEcCtD
Cinacalcet—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000313	0.00265	CcSEcCtD
Cinacalcet—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000312	0.00264	CcSEcCtD
Cinacalcet—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000312	0.00263	CcSEcCtD
Cinacalcet—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000311	0.00263	CcSEcCtD
Cinacalcet—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000311	0.00263	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.00262	CcSEcCtD
Cinacalcet—Fluoxetine—HTR2A—chronic obstructive pulmonary disease	0.000306	0.0644	CrCbGaD
Cinacalcet—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000301	0.00254	CcSEcCtD
Cinacalcet—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.00253	CcSEcCtD
Cinacalcet—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.00253	CcSEcCtD
Cinacalcet—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.0003	0.00886	CbGpPWpGaD
Cinacalcet—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000297	0.00877	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.0025	CcSEcCtD
Cinacalcet—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000296	0.0025	CcSEcCtD
Cinacalcet—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000296	0.0025	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000295	0.00872	CbGpPWpGaD
Cinacalcet—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000293	0.00866	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000293	0.00865	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00245	CcSEcCtD
Cinacalcet—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000288	0.00243	CcSEcCtD
Cinacalcet—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.00243	CcSEcCtD
Cinacalcet—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000287	0.00848	CbGpPWpGaD
Cinacalcet—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000285	0.00842	CbGpPWpGaD
Cinacalcet—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000284	0.0024	CcSEcCtD
Cinacalcet—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.0024	CcSEcCtD
Cinacalcet—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000282	0.00238	CcSEcCtD
Cinacalcet—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000282	0.00833	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00236	CcSEcCtD
Cinacalcet—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000278	0.00235	CcSEcCtD
Cinacalcet—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000275	0.00812	CbGpPWpGaD
Cinacalcet—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00232	CcSEcCtD
Cinacalcet—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00232	CcSEcCtD
Cinacalcet—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000273	0.00231	CcSEcCtD
Cinacalcet—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.0023	CcSEcCtD
Cinacalcet—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00027	0.00798	CbGpPWpGaD
Cinacalcet—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000269	0.00227	CcSEcCtD
Cinacalcet—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00227	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000268	0.00792	CbGpPWpGaD
Cinacalcet—Propranolol—ADRB2—chronic obstructive pulmonary disease	0.000267	0.0563	CrCbGaD
Cinacalcet—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00224	CcSEcCtD
Cinacalcet—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00224	CcSEcCtD
Cinacalcet—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000264	0.00779	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000261	0.00772	CbGpPWpGaD
Cinacalcet—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00026	0.0022	CcSEcCtD
Cinacalcet—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00219	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000259	0.00766	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000256	0.00757	CbGpPWpGaD
Cinacalcet—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000255	0.00216	CcSEcCtD
Cinacalcet—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000255	0.00216	CcSEcCtD
Cinacalcet—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000254	0.0075	CbGpPWpGaD
Cinacalcet—Rash—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00214	CcSEcCtD
Cinacalcet—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00214	CcSEcCtD
Cinacalcet—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00214	CcSEcCtD
Cinacalcet—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00214	CcSEcCtD
Cinacalcet—Headache—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00212	CcSEcCtD
Cinacalcet—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00212	CcSEcCtD
Cinacalcet—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.00212	CcSEcCtD
Cinacalcet—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00025	0.00211	CcSEcCtD
Cinacalcet—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000248	0.00734	CbGpPWpGaD
Cinacalcet—Rash—Montelukast—chronic obstructive pulmonary disease	0.000248	0.00209	CcSEcCtD
Cinacalcet—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000248	0.00209	CcSEcCtD
Cinacalcet—Depression—Prednisone—chronic obstructive pulmonary disease	0.000247	0.00209	CcSEcCtD
Cinacalcet—Headache—Montelukast—chronic obstructive pulmonary disease	0.000246	0.00208	CcSEcCtD
Cinacalcet—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000243	0.00206	CcSEcCtD
Cinacalcet—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00204	CcSEcCtD
Cinacalcet—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00202	CcSEcCtD
Cinacalcet—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00202	CcSEcCtD
Cinacalcet—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000239	0.00706	CbGpPWpGaD
Cinacalcet—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00201	CcSEcCtD
Cinacalcet—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00201	CcSEcCtD
Cinacalcet—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00201	CcSEcCtD
Cinacalcet—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000234	0.00197	CcSEcCtD
Cinacalcet—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000232	0.00687	CbGpPWpGaD
Cinacalcet—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.00195	CcSEcCtD
Cinacalcet—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00023	0.00194	CcSEcCtD
Cinacalcet—Propranolol—CYP1A1—chronic obstructive pulmonary disease	0.000229	0.0483	CrCbGaD
Cinacalcet—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000229	0.00677	CbGpPWpGaD
Cinacalcet—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.0019	CcSEcCtD
Cinacalcet—Propranolol—CYP1A2—chronic obstructive pulmonary disease	0.000221	0.0466	CrCbGaD
Cinacalcet—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00022	0.0065	CbGpPWpGaD
Cinacalcet—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000218	0.00643	CbGpPWpGaD
Cinacalcet—Fluoxetine—ALB—chronic obstructive pulmonary disease	0.000209	0.0441	CrCbGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000209	0.00617	CbGpPWpGaD
Cinacalcet—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000208	0.00616	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000205	0.00606	CbGpPWpGaD
Cinacalcet—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000201	0.0017	CcSEcCtD
Cinacalcet—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00168	CcSEcCtD
Cinacalcet—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000197	0.00582	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000196	0.0058	CbGpPWpGaD
Cinacalcet—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.00165	CcSEcCtD
Cinacalcet—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00164	CcSEcCtD
Cinacalcet—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000192	0.00566	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000185	0.00547	CbGpPWpGaD
Cinacalcet—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000184	0.00545	CbGpPWpGaD
Cinacalcet—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000184	0.00545	CbGpPWpGaD
Cinacalcet—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000179	0.00151	CcSEcCtD
Cinacalcet—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000177	0.00149	CcSEcCtD
Cinacalcet—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.00146	CcSEcCtD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000172	0.0051	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000171	0.00506	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000168	0.00497	CbGpPWpGaD
Cinacalcet—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00142	CcSEcCtD
Cinacalcet—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000167	0.00495	CbGpPWpGaD
Cinacalcet—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000167	0.00141	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000165	0.00489	CbGpPWpGaD
Cinacalcet—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000165	0.00488	CbGpPWpGaD
Cinacalcet—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00139	CcSEcCtD
Cinacalcet—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00139	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000164	0.00138	CcSEcCtD
Cinacalcet—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.00135	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000158	0.00468	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000158	0.00468	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000158	0.00466	CbGpPWpGaD
Cinacalcet—Infection—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00133	CcSEcCtD
Cinacalcet—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00131	CcSEcCtD
Cinacalcet—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000153	0.0013	CcSEcCtD
Cinacalcet—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00127	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.00015	0.00444	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000145	0.00429	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000145	0.00428	CbGpPWpGaD
Cinacalcet—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00122	CcSEcCtD
Cinacalcet—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.00121	CcSEcCtD
Cinacalcet—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000142	0.0012	CcSEcCtD
Cinacalcet—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00117	CcSEcCtD
Cinacalcet—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00116	CcSEcCtD
Cinacalcet—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.00116	CcSEcCtD
Cinacalcet—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.00116	CcSEcCtD
Cinacalcet—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00115	CcSEcCtD
Cinacalcet—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00115	CcSEcCtD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000136	0.00401	CbGpPWpGaD
Cinacalcet—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.004	CbGpPWpGaD
Cinacalcet—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00114	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000131	0.00388	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00109	CcSEcCtD
Cinacalcet—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.00109	CcSEcCtD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.00377	CbGpPWpGaD
Cinacalcet—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.00377	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.00377	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000126	0.00371	CbGpPWpGaD
Cinacalcet—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000126	0.00106	CcSEcCtD
Cinacalcet—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00105	CcSEcCtD
Cinacalcet—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00105	CcSEcCtD
Cinacalcet—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000124	0.00367	CbGpPWpGaD
Cinacalcet—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.0036	CbGpPWpGaD
Cinacalcet—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00012	0.00355	CbGpPWpGaD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.00353	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000983	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000116	0.00342	CbGpPWpGaD
Cinacalcet—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000957	CcSEcCtD
Cinacalcet—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000112	0.00331	CbGpPWpGaD
Cinacalcet—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000944	CcSEcCtD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00324	CbGpPWpGaD
Cinacalcet—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000913	CcSEcCtD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000108	0.00319	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000108	0.00318	CbGpPWpGaD
Cinacalcet—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000882	CcSEcCtD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00305	CbGpPWpGaD
Cinacalcet—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.00301	CbGpPWpGaD
Cinacalcet—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000849	CcSEcCtD
Cinacalcet—Rash—Prednisone—chronic obstructive pulmonary disease	9.96e-05	0.000841	CcSEcCtD
Cinacalcet—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.95e-05	0.000841	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.93e-05	0.00293	CbGpPWpGaD
Cinacalcet—Headache—Prednisone—chronic obstructive pulmonary disease	9.9e-05	0.000836	CcSEcCtD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.87e-05	0.00292	CbGpPWpGaD
Cinacalcet—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.84e-05	0.00291	CbGpPWpGaD
Cinacalcet—Nausea—Prednisone—chronic obstructive pulmonary disease	9.39e-05	0.000793	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.94e-05	0.00264	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.88e-05	0.00262	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.87e-05	0.00262	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	8.71e-05	0.00257	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.68e-05	0.00256	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.58e-05	0.00254	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.36e-05	0.00247	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.12e-05	0.0024	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.07e-05	0.00238	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	8.01e-05	0.00237	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.96e-05	0.00235	CbGpPWpGaD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.85e-05	0.00232	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.76e-05	0.00229	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.35e-05	0.00217	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.27e-05	0.00215	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.22e-05	0.00213	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.21e-05	0.00213	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.11e-05	0.0021	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	7.06e-05	0.00208	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.45e-05	0.00191	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.02e-05	0.00178	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	5.97e-05	0.00177	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.93e-05	0.00175	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.93e-05	0.00175	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.67e-05	0.00168	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.66e-05	0.00167	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.61e-05	0.00166	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.53e-05	0.00163	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	5.48e-05	0.00162	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.45e-05	0.00161	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.41e-05	0.0016	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	5.38e-05	0.00159	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	5.38e-05	0.00159	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.24e-05	0.00155	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.17e-05	0.00153	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.17e-05	0.00153	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	5.12e-05	0.00151	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	5.12e-05	0.00151	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.1e-05	0.00151	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.03e-05	0.00149	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.8e-05	0.00142	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.72e-05	0.00139	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.68e-05	0.00138	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.65e-05	0.00137	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.62e-05	0.00136	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.56e-05	0.00135	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.44e-05	0.00131	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.38e-05	0.00129	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.34e-05	0.00128	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	4.22e-05	0.00125	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.93e-05	0.00116	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.9e-05	0.00115	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.88e-05	0.00115	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.61e-05	0.00107	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.58e-05	0.00106	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.57e-05	0.00106	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.56e-05	0.00105	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.51e-05	0.00104	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.43e-05	0.00101	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.38e-05	0.000999	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.94e-05	0.00087	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.79e-05	0.000825	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.76e-05	0.000815	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.72e-05	0.000803	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.69e-05	0.000796	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.55e-05	0.000753	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.53e-05	0.000746	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.37e-05	0.000699	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.3e-05	0.00068	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.14e-05	0.000632	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.83e-05	0.00054	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.78e-05	0.000525	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.7e-05	0.000504	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.65e-05	0.000488	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.48e-05	0.000439	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.47e-05	0.000434	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.34e-05	0.000396	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.26e-05	0.000372	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.24e-05	0.000367	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.23e-05	0.000365	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.16e-05	0.000342	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.13e-05	0.000335	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.03e-05	0.000304	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.01e-05	0.0003	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.7e-06	0.000287	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	9.59e-06	0.000283	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.45e-06	0.000279	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.96e-06	0.000265	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.75e-06	0.000259	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.72e-06	0.000258	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.6e-06	0.000254	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.06e-06	0.000238	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.01e-06	0.000237	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.59e-06	0.000224	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.73e-06	0.000199	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.63e-06	0.000196	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.18e-06	0.000183	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	6.09e-06	0.00018	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.86e-06	0.000173	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.83e-06	0.000172	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	5.16e-06	0.000153	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.94e-06	0.000146	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.98e-06	0.000118	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.81e-06	0.000113	CbGpPWpGaD
